Juan Garcia Valero

Sobre mi

Publicacions destacades

• Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target

  Autors:

  Dobano-Lopez, Celia; Valero, Juan Garcia; Araujo-Ayala, Ferran; Nadeu, Ferran; Gava, Fabien;

  (...)

  Lopez-Guillermo, Armando; Magnano, Laura; Colomer, Dolors; Bezombes, Christine; Perez-Galan, Patricia.

  Veure llistat complet d'autors

  Referència: Blood Cancer Journal 2024.

• A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses

  Autors:

  Araujo-Ayala, Ferran; Dobano-Lopez, Celia; Valero, Juan Garcia; Nadeu, Ferran; Gava, Fabien;

  (...)

  Lopez-Guillermo, Armando; Gine, Eva; Colomer, Dolors; Bezombes, Christine; Perez-Galan, Patricia.

  Veure llistat complet d'autors

  Referència: Leukemia 2023.

• Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma

  Autors:

  Melchor, Javier; Garcia-Lacarte, Marcos; Grijalba, Sara C; Arnaiz-Leche, Adrian; Pascual, Marien;

  (...)

  Novo, Francisco J; Valero, Juan Garcia; Perez-Galan, Patricia; Martinez-Climent, Jose A; Roa, Sergio.

  Veure llistat complet d'autors

  Referència: Journal For Immunotherapy Of Cancer 2023.

• The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma

  Autors:

  Valero, Juan Garcia; Matas-Cespedes, Alba; Arenas, Fabian; Rodriguez, Vanina; Carreras, Joaquim;

  (...)

  Cid, Maria C; Campo, Elias; Lopez-Guillermo, Armando; Colomer, Dolors; Perez-Galan, Patricia.

  Veure llistat complet d'autors

  Referència: Leukemia 2021.

• PI3Kδ inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclax

  Autors:

  Serrat, Neus; Guerrero-Hernandez, Martina; Matas-Cespedes, Alba; Yahiaoui, Anella; Valero, Juan G;

  (...)

  Hodson, Daniel J; Lopez-Guillermo, Armando; Colomer, Dolors; Tannheimer, Stacey; Perez-Galan, Patricia.

  Veure llistat complet d'autors

  Referència: Blood Advances 2020.

• Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens

  Autors:

  Vidal-Crespo, Anna; Matas-Cespedes, Alba; Rodriguez, Vanina; Rossi, Cedric; Valero, Juan G;

  (...)

  Bezombes, Christine; van Bueren, Jeroen Lammerts; Chiu, Christopher; Doshi, Parul; Perez-Galan, Patricia.

  Veure llistat complet d'autors

  Referència: Haematologica 2020.

• Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia

  Autors:

  Gimenez, Neus; Martinez-Trillos, Alejandra; Montraveta, Arnau; Lopez-Guerra, Monica; Rosich, Laia;

  (...)

  Lopez-Otin, Carlos; Lopez-Guillermo, Armando; Campo, Elias; Colomer, Dolors; Villamor, Neus.

  Veure llistat complet d'autors

  Referència: Haematologica 2019.

• The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma

  Autors:

  Esteve-Arenys, A; Valero, J G; Chamorro-Jorganes, A; Gonzalez, D; Rodriguez, V;

  (...)

  Martinez, A; Rymkiewicz, G; Perez-Galan, P; Lopez-Guillermo, A; Roue, G.

  Veure llistat complet d'autors

  Referència: Oncogene 2018.

Projectes destacats

• Transpyrenean network of advanced therapies in non-Hodgkin lymphoma - THERAVLINFO (INTERREG-POCTEFA program EFA123/1)

  Investigador/a principal: Dolors Colomer Pujol, Patricia Pérez Galán

  Durada: 01/01/2024

  Web: http://theravlinfo.eu/